National LGBT Cancer Network calls out major media outlets for misinformation on transgender cancer
Media coverage on a purported connection between gender-affirming hormone therapy and cancer is misleading.
- Media coverage on a purported connection between gender-affirming hormone therapy and cancer is misleading.
- "The articles artificially elevate rare case reports as scientific 'evidence' of a connection between these therapies and cancer," says Scout, executive director of the network.
- "Simply repeating a provider's hypothesis that a treatment might relate to cancer does not constitute scientific evidence.
- "The National LGBTQI+ Cancer Network looks forward to the day media outlets raise alarms about real issues related to trans cancer, instead of attempting to feed false right wing narratives designed to increase our communities' risk."